Evidence map›Paper›PMID 36371560›Full record

ArticleCommunications biology2022

Biosynthesis of cannabinoid precursor olivetolic acid in genetically engineered Yarrowia lipolytica.

Jingbo Ma, Yang Gu, Peng Xu

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Toward Complex Polyketide Biosynthesis inJournal of microbiology and biotechnology · 2026
    Review
  2. Article
  3. Review
  4. Biodesign research · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Bioengineering of the Marine DiatomInternational journal of molecular sciences · 2023
    Article
  10. Horticulture research · 2023
    Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Jingbo MaDepartment of Chemical, Biochemical and Environmental Engineering, University of Maryland, Baltimore County, Baltimore, MD, 21250, USA.
Yang GuDepartment of Chemical, Biochemical and Environmental Engineering, University of Maryland, Baltimore County, Baltimore, MD, 21250, USA.
Peng XuDepartment of Chemical, Biochemical and Environmental Engineering, University of Maryland, Baltimore County, Baltimore, MD, 21250, USA. peng.xu@gtiit.edu.cn.ORCID http://orcid.org/0000-0002-0999-8546
Guangdong Technion-Israel Institute of Technology · CNNanjing Normal University · CNWest Anhui University · CN

Funding

National Science Foundation (NSF) CBET-1805139
6 · The paper itself

Abstract

Engineering microbes to produce plant-derived natural products provides an alternate solution to obtain bioactive products. Here we report a systematic approach to sequentially identify the rate-limiting steps and improve the biosynthesis of the cannabinoid precursor olivetolic acid (OLA) in Yarrowia lipolytica. We find that Pseudomonas sp LvaE encoding a short-chain acyl-CoA synthetase can efficiently convert hexanoic acid to hexanoyl-CoA. The co-expression of the acetyl-CoA carboxylase, the pyruvate dehydrogenase bypass, the NADPH-generating malic enzyme, as well as the activation of peroxisomal β-oxidation pathway and ATP export pathway are effective strategies to redirect carbon flux toward OLA synthesis. Implementation of these strategies led to an 83-fold increase in OLA titer, reaching 9.18 mg/L of OLA in shake flask culture. This work may serve as a baseline for engineering cannabinoids biosynthesis in oleaginous yeast species.

Indexed as

CannabinoidsYarrowiaMetabolic EngineeringSalicylatesCannabinoidsolivetolic acidSalicylates

Identifiers

PMID36371560
PMCPMC9653464
OpenAlexW4308831855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.